Industries > Pharma > Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine

PUBLISHED: 01 August 2017
PAGES: 227
PRODUCT CODE: PHA0219

Clear
WOOCS 2.2.1

The Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027: Analysis and Forecasts for Mammalian Cell Cultures, Microbial Fermentations, Other Expression Systems, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines and Geography report reviews the contract active pharmaceutical ingredient (API) manufacturing market for biologics. This study gives quantitative and qualitative analysis for that overall world market, as well as for countries and other submarkets, including the mammalian cell culture and microbial fermentation segments. This report assesses leading applications and significant developments within each, as well as drivers and restraints for them. Future trends that will affect the biotech API manufacturing services market are also examined. In addition, this study profiles leading contract manufacturing organisations (CMOs) in the outsourcing market and assesses their outlooks. Visiongain provides forecasts revenues for the period 2016 to 2027 for the biotech API manufacturing services market, as well as for therapeutic applications.

How this 227 page report delivers:
• Provides qualitative and quantitative analysis of the leading submarkets the period 2017-2027. Visiongain forecasts revenues and their growth for these submarkets:
– Mammalian cell culture
– Microbial fermentation
– Other expression platforms

• Provides qualitative and quantitative analysis of the leading contract API biological drug applications for the period 2017-2027. Visiongain forecasts contract API drug revenues to 2027 for these individual segments:
– Monoclonal antibody (mAb) therapies
– Vaccines
– Insulin therapies
– Interferon therapies
– Growth hormones.

Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027

• Find forecasts of the leading therapeutic and national markets from 2016 to 2027:
– The EU, including the five leading markets (UK, Germany, France, Italy and Spain).
– The US
– Japan
– Switzerland
– Emerging markets such as the BRIC (Brazil, Russia, India, and China) countries, South Korea and Singapore.

• Profiles leading global and national companies that offer biotech API manufacturing services to the pharmaceutical industry. For each company, current services offered, recent developments and outlooks are discussed. Leading CMOs profiled in this chapter are:
– Boehringer Ingelheim BioXcellence
– Celltrion
– DSM Biologics
– Lonza
– Samsung BioLogics
– Cytovance Biologics
– Fujifilm Diosynth Biotechnologies
– Operations of leading biopharma companies, such as AbbVie, GSK and Novartis.

• Discover the regulatory outlook for biotech API manufacturing in leading regional and national markets in 2017, as well as predicted developments for the period to 2027.

• Identify important drug development and technology trends that will affect CMOs, their clients and other market participants from 2017. The report also contains SWOT and STEP analysis of the industry and market.

• Find profiles for leading CMOs offering biological drug API manufacturing services to pharmaceutical companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

READ

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

READ

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

READ

Categories

Category